Interest of Medial Partial Arthrodesis in Degenerative and Inflammatory Damage of Lisfranc Tarsometatarsal Joint.

NCT04937764•Central Hospital, Nancy, France

Summary

Research Hypothesis: Lisfranc tarsometatarsal joint arthrodesis is a reliable surgical procedure, allowing the restoration of satisfactory function and a painless foot with an acceptable complication rate. Objective of the study: To analyze the clinical and radiographic results in the medium term of arthrodesis of the Lisfranc tarsometatarsal joint in cases of primary osteoarthritis, post-traumatic osteoarthritis or in cases of inflammatory pathology.

Detailed Description

Data collection by return to the patient record: * Clinical score * Analysis of imagery (X-rays, CT scan, ) The patients included were those who had undergone arthrodesis of the medial Lisfranc joint

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•All patients who underwent Lisfranc arthrodesis for primary post-traumatic osteoarthritis or inflammatory disease between January 2008 and December 2020 in
•Age \> 18 ans

Exclusion Criteria

•Follow-up \< 6 months
•Lost to follow-up
•lack of data in the patient record.

Locations (1)

CHRU NANCY, Central Hospital

Nancy, Meurthe Et Moselle, France

Key Dates

Start Date

April 8, 2008

Primary Completion Date

January 27, 2009

Completion Date

October 30, 2021

Last Updated

June 24, 2021

Enrollment

ESTIMATED participants

Conditions

Arthritis Foot

Evaluation of the Treatment of Arthritis and the Correction of Bone Alignment Default of the Toes With Lync

NCT06888934

Arthritis FootBone Alignment Defaults

View study

COMPLETED

Artoss Foot and Ankle Surgery Registry

NCT04503759

Arthritis FootTrauma Injury+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 24, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions